A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Promoter analysis of the human SLC7A7 gene encoding y(+)L amino acid transporter-1 (y(+)LAT-1)
Tekijät: Mykkanen J, Toivonen M, Kleemola M, Savontaus ML, Simell O, Aula P, Huoponen K
Kustantaja: ACADEMIC PRESS INC ELSEVIER SCIENCE
Julkaisuvuosi: 2003
Lehti:: Biochemical and Biophysical Research Communications
Tietokannassa oleva lehden nimi: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Lehden akronyymi: BIOCHEM BIOPH RES CO
Vuosikerta: 301
Numero: 4
Aloitussivu: 855
Lopetussivu: 861
Sivujen määrä: 7
ISSN: 0006-291X
DOI: https://doi.org/10.1016/S0006-291X(03)00054-8
The human SLC7A7 gene on chromosome 14q11.2 encodes the y(+)L amino acid transporter-1 (y(+)LAT-1) protein that transports, together with the 4F2hc cell surface antigen, cationic amino acids through the basolateral membrane of epithelial cells in the small intestine and kidney. The SLC7A7 gene comprises 11 exons, but the first two are not translated. Mutations in the coding region of the SLC7A7 gene cause a rare autosomal disorder, lysinuric protein intolerance (LPI). We have now investigated the expression levels and putative 5' promoter elements of the SLC7A7 The 5' region of the first untranslated exon contains no TATA-box, Inr elements nor other classical promoter elements, but has instead other putative transcription factor binding sequences. The E-box and AP-2 elements were able to bind proteins in HEK293 cells and adult kidney tissue extracts, but not in fibroblasts. Using transient transfection and luciferase reporter gene studies, we showed that the first two introns located in the untranslated region contained transcriptional enhancer elements. Northern blot analysis showed low and equal SLC7A7 mRNA levels in the control and LPI patient fibroblastoid and lymphoblast cells. (C) 2003 Elsevier Science (USA). All rights reserved.